Why Samsung?
Elon Musk's brain-computer interface company Neuralink is considering partnering with Samsung Electronics for the mass production of its fourth-generation chip. This move could be Neuralink's biggest production leap yet. While the company can currently produce chips in limited quantities, Samsung's massive semiconductor factories (fabs) offer capacity for millions of units.
The South Korean tech giant, one of the world's largest semiconductor manufacturers, specializes in 3-nanometer (nm) and smaller fabrication processes. Neuralink's chips feature dense neuron connections requiring high-precision manufacturing. Samsung's expertise in this area could be critical for producing chips that process neural signals effectively.
About Samsung's Semiconductor Edge
Samsung became the first company globally to start chip production using 3nm GAA (Gate-All-Around) technology in 2022. This technology promises lower power consumption and higher performance. Since Neuralink's brain chips are designed to monitor and stimulate thousands of neurons simultaneously in the human brain, such efficiency is vital. Additionally, Samsung's factory in Taylor, Texas, could offer logistical proximity to Neuralink's California headquarters.
The Importance of a Production Partnership for Neuralink
Neuralink has so far produced its chips in small batches at its own facilities. But after starting human trials in 2024, the company could face a surge in demand. Neuralink aims to enable paralyzed patients to use computers with their thoughts. This technology holds promise for spinal cord injuries and neurological diseases.
A deal with Samsung could give Neuralink the capacity to produce hundreds of thousands of chips per month. By comparison, similar to Tesla's strategy for electric vehicle batteries, Neuralink could outsource production to focus on R&D. Elon Musk has previously described Tesla's production challenges as 'production hell'; Neuralink wants to avoid that trap.
Previous Partners and Challenges
Neuralink had previously approached Taiwanese TSMC for chip production but failed to reach an agreement. TSMC's capacity is largely occupied by major clients like Apple and NVIDIA, creating a bottleneck for Neuralink. Samsung, however, can offer more flexible capacity. However, producing sensitive biomedical chips requires stricter quality control than standard semiconductors. Samsung's certification processes in this area could also accelerate Neuralink's FDA approval process.
Experts estimate that if this partnership materializes, Neuralink could produce over 10,000 implantable chips per year by 2026. The company currently can only make a few hundred chips per year. This scale is a critical threshold for the technology's commercialization.
So, could this partnership bring brain-computer interfaces into the mainstream? If Samsung's production power merges with Neuralink's vision, a new era in human-machine interaction could begin. The technology has the potential to revolutionize not only medicine but also gaming, communication, and even AI training. Do you think this collaboration will achieve more than just curing paralysis as Neuralink promises?